Search This Blog

Wednesday, July 1, 2026

BridgeBio raises up to $1B in high-premium convertible preferred equity

 

BridgeBio raises up to $1B in high-premium convertible preferred equity led by Sixth Street and HealthCare Royalty

  • Financing intended to strengthen BridgeBio's balance sheet and support funding for current and upcoming drug launches.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)